<p>/PRNewswire/ -- Agentis Longevity，作為行業領先的最佳長壽醫療和健康公司，今天宣佈收購 BioDesign，這是一家位於佛羅里達州的頂級長壽醫療公司，專注於卓越的長壽和健康醫療。BioDesign 由 Jeremy Avner、Jimmy Baker 和 Ian Costello 共同創立，以其基於科學的方法優化長期健康而聞名。</p>
<p>該收購顯著擴大了 Agentis Longevity 在長壽和優化領域的影響力，涵蓋了坦帕、奧蘭多、湖瑪麗和墨爾本的多個地點，使其能夠提供更深入的診斷能力、擴展的臨牀服務以及更全面的表現和預防服務生態系統。</p>
<p>憑藉 BioDesign 的臨牀專業知識，Agentis Longevity 將能夠在其項目中提供更大的個性化服務，包括代謝健康、激素優化、心血管健康、表現恢復、細胞再生和長期健康延續。</p>
<p>&#34;BioDesign 對個性化、數據驅動護理的承諾與我們作為最值得信賴、最具變革性的長壽護理提供者的使命完美契合，&#34; Agentis Longevity 首席執行官 Jimmy St. Louis 表示。&#34;此次收購增強了我們提供基於科學的高度個性化項目的能力，滿足客户的期望。我們共同構建了全國最全面的長壽平台。&#34;</p>
<p>BioDesign 的聯合創始人 Jeremy Avner 將以戰略臨牀領導角色加入 Agentis Longevity，推動診斷策略、治療編程和創新。BioDesign 在坦帕、奧蘭多、湖瑪麗和墨爾本設有多個地點。</p>
<p>&#34;在 BioDesign，我們一直專注於幫助男性更深入地瞭解自己的身體，並創建基於精準數據的長壽項目，&#34; BioDesign Men's Clinic 的聯合創始人 Jeremy Avner 表示。&#34;與 Agentis Longevity 的合作使我們有機會將這一使命帶給更廣泛的受眾。憑藉 Agentis 的全國覆蓋和對基於表現的醫療的承諾，我們可以提升個性化護理的標準，幫助更多人優化他們的健康壽命，今天以及未來幾十年。&#34;</p>
<p>&#34;從臨牀角度來看，此次收購使我們能夠更好地對齊消費者的利益和需求，提供高質量、安全和創新的醫療服務，&#34; BioDesign 的聯合創始人 Jimmy Barker 表示。&#34;通過將我們的先進診斷和治療模型整合到 Agentis 生態系統中，我們可以提供更精確、醫學嚴謹的護理，支持長期表現、預防和健康壽命延續。&#34;</p>
<p>&#34;這一合作代表了一個強大的機會，可以在保持我們對基於科學的個性化護理承諾的同時，擴大 BioDesign 的模式，&#34; BioDesign 的聯合創始人 Ian Costello 表示。&#34;我們與 Agentis Longevity 的共同願景是基於這樣的信念：人們應當獲得高質量、安全和創新的醫療服務，以符合他們的目標，而不是一刀切的系統。我們將繼續提升全國範圍內長壽和表現醫學的標準。&#34;</p>
<p>BioDesign 與 Agentis Longevity 的整合將增強以下服務：</p>
<ul>
<li>先進的診斷測試和生物標誌物分析</li>
<li>個性化長壽健康項目</li>
<li>激素、代謝和心血管優化</li>
<li>恢復、再生和表現療法</li>
<li>遠程監測和持續生物標誌物追蹤</li>
<li>全國範圍內的禮賓和移動服務</li>
</ul>
<p>此次收購進一步鞏固了 Agentis Longevity 作為快速增長的長壽和人類表現領域的領先力量，支持運動員、企業高管、娛樂人士以及致力於過上更強壯、更長久和更健康生活的個人。</p>
<p><strong>關於 Agentis Longevity</strong> Agentis Longevity 是精準健康、表現和長壽醫學的領導者。該公司提供基於證據的項目，幫助客户優化健康、延長表現和增強壽命，通過基於科學的個性化護理。Agentis 在長壽領域設定了質量標準，將嚴格的科學與現實世界的可及性相結合。欲瞭解更多信息，請訪問 www.agentislongevity.com</p>
<p><strong>關於 BioDesign Men's Clinic</strong> BioDesign Men's Clinic 是一家專注於精準醫療的私人診所，專門提供先進的診斷、表現優化和基於長壽的治療，服務於男性。由 Jeremy Avner 共同創立，BioDesign 提供基於生物標誌物數據、先進測試和基於證據的項目的個性化護理，旨在改善長期活力和整體健康。</p>
<p>來源：Agentis Longevity</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA1Jk5ld3NJdGVtSWQ9Tlk4MDgyOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDUxMDI4UFJfTkVXU19VU1BSX19fX19OWTgwODI4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA1Jk5ld3NJdGVtSWQ9Tlk4MDgyOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDUxMDI4UFJfTkVXU19VU1BSX19fX19OWTgwODI4"/></p>

<p>Agentis Longevity 宣佈收購位於佛羅里達的長壽醫療公司 BioDesign。這項收購增強了 Agentis 在個性化長壽和表現醫學方面的能力，擴展了其診斷和臨牀服務。BioDesign 的聯合創始人將以領導角色加入 Agentis，共同推進提供基於科學的個性化醫療的使命。此次整合旨在改善客户的健康壽命和表現，鞏固 Agentis 在不斷增長的長壽領域中的地位</p>

<p>, /PRNewswire/ -- Agentis Longevity, an industry leader in best-in-class longevity healthcare and medicine, today announced the acquisition of BioDesign, a premier, Florida based longevity healthcare company, specializing in premier longevity and wellness healthcare. Co-founded by Jeremy Avner, Jimmy Baker, and Ian Costello, BioDesign has become known for their science-backed approach to optimizing long-term health.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Agentis Longevity，作為行業領先的最佳長壽醫療和健康公司，今天宣佈收購 BioDesign，這是一家位於佛羅里達州的頂級長壽醫療公司，專注於卓越的長壽和健康醫療。BioDesign 由 Jeremy Avner、Jimmy Baker 和 Ian Costello 共同創立，以其基於科學的方法優化長期健康而聞名。</p>
</div><p>With locations in Tampa, Orlando, Lake Mary, and Melbourne, Florida this acquisition significantly expands Agentis Longevity's footprint in the longevity and optimization space, enabling deeper diagnostic capabilities, expanded clinical offerings, and a more comprehensive ecosystem of performance and preventative services.</p>
<div class="lb-trans"><p>該收購顯著擴大了 Agentis Longevity 在長壽和優化領域的影響力，涵蓋了坦帕、奧蘭多、湖瑪麗和墨爾本的多個地點，使其能夠提供更深入的診斷能力、擴展的臨牀服務以及更全面的表現和預防服務生態系統。</p>
</div><p>With BioDesign's clinical expertise, Agentis Longevity will now deliver even greater personalization across its programs including metabolic health, hormone optimization, cardiovascular health, performance recovery, cellular regeneration, and long-term healthspan extension.</p>
<div class="lb-trans"><p>憑藉 BioDesign 的臨牀專業知識，Agentis Longevity 將能夠在其項目中提供更大的個性化服務，包括代謝健康、激素優化、心血管健康、表現恢復、細胞再生和長期健康延續。</p>
</div><p>&#34;BioDesign's commitment to personalized, data-driven care aligns perfectly with our mission to drive the standard as the most trusted, transformative provider of longevity care.,&#34; said Jimmy St. Louis, CEO, Agentis Longevity. &#34;This acquisition strengthens our ability to deliver the science-backed, highly individualized programs our clients expect. Together, we're building the most comprehensive longevity platform in the country.&#34;</p>
<div class="lb-trans"><p>&#34;BioDesign 對個性化、數據驅動護理的承諾與我們作為最值得信賴、最具變革性的長壽護理提供者的使命完美契合，&#34; Agentis Longevity 首席執行官 Jimmy St. Louis 表示。&#34;此次收購增強了我們提供基於科學的高度個性化項目的能力，滿足客户的期望。我們共同構建了全國最全面的長壽平台。&#34;</p>
</div><p>BioDesign Co-Founder Jeremy Avner will join Agentis Longevity in a strategic clinical leadership role to advance diagnostic strategy, therapeutic programming, and innovation. BioDesign has locations in Tampa, Orlando, Lake Mary, and Melbourne.</p>
<div class="lb-trans"><p>BioDesign 的聯合創始人 Jeremy Avner 將以戰略臨牀領導角色加入 Agentis Longevity，推動診斷策略、治療編程和創新。BioDesign 在坦帕、奧蘭多、湖瑪麗和墨爾本設有多個地點。</p>
</div><p>&#34;At BioDesign, our focus has always been to help men understand their bodies at a deeper level and create longevity-focused programs rooted in precision data,&#34; said Jeremy Avner, Co-Founder of BioDesign Men's Clinic. &#34;Partnering with Agentis Longevity gives us the opportunity to bring that mission to a broader audience. With Agentis' national reach and commitment to performance-based medicine, we can elevate the standard of personalized care and help more people optimize their healthspan today and for decades to come.&#34;</p>
<div class="lb-trans"><p>&#34;在 BioDesign，我們一直專注於幫助男性更深入地瞭解自己的身體，並創建基於精準數據的長壽項目，&#34; BioDesign Men's Clinic 的聯合創始人 Jeremy Avner 表示。&#34;與 Agentis Longevity 的合作使我們有機會將這一使命帶給更廣泛的受眾。憑藉 Agentis 的全國覆蓋和對基於表現的醫療的承諾，我們可以提升個性化護理的標準，幫助更多人優化他們的健康壽命，今天以及未來幾十年。&#34;</p>
</div><p>&#34;From a clinical standpoint, this acquisition allows us to better align the interests and needs of consumers with high-quality, safe, and innovative healthcare,&#34; said Jimmy Barker, Co-Founder of BioDesign. &#34;By integrating our advanced diagnostics and therapeutic model into the Agentis ecosystem, we can deliver even more precise, medically rigorous care that supports long-term performance, prevention, and healthspan extension.&#34;</p>
<div class="lb-trans"><p>&#34;從臨牀角度來看，此次收購使我們能夠更好地對齊消費者的利益和需求，提供高質量、安全和創新的醫療服務，&#34; BioDesign 的聯合創始人 Jimmy Barker 表示。&#34;通過將我們的先進診斷和治療模型整合到 Agentis 生態系統中，我們可以提供更精確、醫學嚴謹的護理，支持長期表現、預防和健康壽命延續。&#34;</p>
</div><p>&#34;This partnership represents a powerful opportunity to scale the BioDesign model while preserving our commitment to science-backed, individualized care,&#34; said Ian Costello, Co-Founder of BioDesign. &#34;Our shared vision with Agentis Longevity is centered on the belief that people deserve access to high-quality, safe, and innovative healthcare that aligns with their goals not a one-size-fits-all system. Together, we will continue elevating the standard for longevity and performance medicine nationwide.&#34;</p>
<div class="lb-trans"><p>&#34;這一合作代表了一個強大的機會，可以在保持我們對基於科學的個性化護理承諾的同時，擴大 BioDesign 的模式，&#34; BioDesign 的聯合創始人 Ian Costello 表示。&#34;我們與 Agentis Longevity 的共同願景是基於這樣的信念：人們應當獲得高質量、安全和創新的醫療服務，以符合他們的目標，而不是一刀切的系統。我們將繼續提升全國範圍內長壽和表現醫學的標準。&#34;</p>
</div><p>The integration of BioDesign into Agentis Longevity will enhance offerings across:</p>
<div class="lb-trans"><p>BioDesign 與 Agentis Longevity 的整合將增強以下服務：</p>
</div><ul>
<li>Advanced diagnostic testing &amp; biomarker analysis</li>
<li>Personalized longevity health programs</li>
<li>Hormone, metabolic, and cardiovascular optimization</li>
<li>Recovery, regeneration, and performance therapies</li>
<li>Remote monitoring and continuous biomarker tracking</li>
<li>Concierge and mobile services nationwide</li>
</ul>
<div class="lb-trans"><ul>
<li>先進的診斷測試和生物標誌物分析</li>
<li>個性化長壽健康項目</li>
<li>激素、代謝和心血管優化</li>
<li>恢復、再生和表現療法</li>
<li>遠程監測和持續生物標誌物追蹤</li>
<li>全國範圍內的禮賓和移動服務</li>
</ul>
</div><p>This acquisition further solidifies Agentis Longevity as a leading force in the rapidly growing longevity and human performance sector, supporting athletes, executives, entertainers, and individuals committed to living stronger, longer, and healthier lives.</p>
<div class="lb-trans"><p>此次收購進一步鞏固了 Agentis Longevity 作為快速增長的長壽和人類表現領域的領先力量，支持運動員、企業高管、娛樂人士以及致力於過上更強壯、更長久和更健康生活的個人。</p>
</div><p><strong>About Agentis Longevity</strong> Agentis Longevity is a leader in precision-based health, performance, and longevity medicine. The company provides evidence-driven programs that empower clients to optimize health, extend performance, and enhance lifespan through science-backed, individualized care. Agentis sets the quality standard in longevity bridging rigorous science with real-world accessibility. For more information please visit www.agentislongevity.com</p>
<div class="lb-trans"><p><strong>關於 Agentis Longevity</strong> Agentis Longevity 是精準健康、表現和長壽醫學的領導者。該公司提供基於證據的項目，幫助客户優化健康、延長表現和增強壽命，通過基於科學的個性化護理。Agentis 在長壽領域設定了質量標準，將嚴格的科學與現實世界的可及性相結合。欲瞭解更多信息，請訪問 www.agentislongevity.com</p>
</div><p><strong>ABOUT BIODESIGN MEN'S CLINIC</strong> BioDesign Men's Clinic is a precision-focused private practice specializing in advanced diagnostics, performance optimization, and longevity-based therapies for men. Co-founded by Jeremy Avner, BioDesign delivers individualized care rooted in biomarker data, advanced testing, and evidence-based programs designed to improve long-term vitality and overall health.</p>
<div class="lb-trans"><p><strong>關於 BioDesign Men's Clinic</strong> BioDesign Men's Clinic 是一家專注於精準醫療的私人診所，專門提供先進的診斷、表現優化和基於長壽的治療，服務於男性。由 Jeremy Avner 共同創立，BioDesign 提供基於生物標誌物數據、先進測試和基於證據的項目的個性化護理，旨在改善長期活力和整體健康。</p>
</div><p>SOURCE Agentis Longevity</p>
<div class="lb-trans"><p>來源：Agentis Longevity</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA1Jk5ld3NJdGVtSWQ9Tlk4MDgyOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDUxMDI4UFJfTkVXU19VU1BSX19fX19OWTgwODI4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY80828&amp;Transmission_Id=202602051028PR_NEWS_USPR_____NY80828&amp;DateId=20260205"/></p>

10:28 ETAgentis Longevity Announces Acquisition of BioDesign, Expanding Its Leadership in Personalized Longevity, Performance Medicine & Advanced Health Optimization

prnewswire

Invesco Nasdaq Biotechnology ETF

生物科技 ETF - VanEck Vectors

基因免疫&健康關懷 ETF - iShares

美國醫療保健供應商 ETF - iShares

動態生物技術與基因組 ETF - Invesco

Longevity Health

基因改革 ETF - ARK

LONGEVITY HEALTH HLDGS INC C/WTS 12/07/2028 (TO PUR COM)

美國醫藥設備 ETF - iShares

醫藥突破 ETF - ALPS

標普健康醫療設備 ETF - SPDR

標普生物技術 ETF - SPDR

2 倍做多納斯達克生物技術 ETF - ProShares

納斯達克生物科技指數 ETF - iShares Nasdaq

LifeX 2050 Longevity Income ETF

醫療業 ETF - SPDR

LifeX 2061 Longevity Income ETF

紐交所高增長板生物技術指數 ETF - First Trust

10:28 ETAgentis Longevity 宣佈收購 BioDesign，進一步擴大其在個性化長壽、性能醫學和先進健康優化領域的領導地位